Doctors say the removal of insulin Mixtard 30, on which some sufferers have relied for more than a decade, would cause significant upheaval for patients and the health service.
Thousands of diabetic patients face changing medication as a pharmaceutical giant plans to withdraw a key treatment from the UK, creating extra work for the NHS at a time when hundreds of jobs are facing the axe.
Doctors say the removal of insulin Mixtard 30, on which some sufferers have relied for more than a decade, would cause significant upheaval for patients and the health service.